HOMB vs XENE

Comparison between Home Bancshares Inc (HOMB, Company) and Xenon Pharmaceuticals Inc (XENE, Company).

HOMB is from the Financial Services sector, while XENE is from the Healthcare sector.

5-Year PerformanceXENE has outperformed HOMB, delivering a return of +22.8% compared to +2.6%

HOMB vs XENE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	HOMB(COMPANY)	XENE(COMPANY)
Market Cap	$5.24B	$5.21B
Max Drawdown	65.40%	90.43%
Sharpe Ratio	-0.06	1.08
5Y Beta	0.82	0.95
Industry	Banks - Regional	Biotechnology
P/E Ratio	11.07	-11.58
Forward P/E	10.74	N/A
PEG Ratio	0.45	-0.28
Dividend Yield	3.06%	N/A
5Y Dividends CAGR	13.37%	N/A
5Y EPS CAGR	12.97%	40.27%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	8.24%	-5.90%
P/S Ratio	5.00	727.44
P/B Ratio	1.24	3.90

Market Cap

Winner

HOMB

$5.24B

XENE

$5.21B

Max Drawdown

Winner

HOMB

65.40%

XENE

90.43%

Sharpe Ratio

HOMB

-0.06

Winner

XENE

1.08

5Y Beta

Winner

HOMB

0.82

XENE

0.95

Industry

HOMB

Banks - Regional

XENE

Biotechnology

P/E Ratio

HOMB

11.07

Winner

XENE

-11.58

Forward P/E

HOMB

10.74

XENE

N/A

PEG Ratio

HOMB

0.45

Winner

XENE

-0.28

Dividend Yield

HOMB

3.06%

XENE

N/A

5Y Dividends CAGR

HOMB

13.37%

XENE

N/A

5Y EPS CAGR

HOMB

12.97%

Winner

XENE

40.27%

Debt to Equity

HOMB

0.00%

XENE

0.00%

Free Cash Flow Yield

Winner

HOMB

8.24%

XENE

-5.90%

P/S Ratio

Winner

HOMB

5.00

XENE

727.44

P/B Ratio

Winner

HOMB

1.24

XENE

3.90

HOMB vs XENE - Historical Returns

Returns include dividend reinvestment.

Period	HOMB	XENE
1 month	+2.44%	-10.36%
3 months	-0.83%	+23.02%
6 months	-2.98%	+14.93%
1 year	+0.39%	+68.34%
5 years(CAGR)	+2.56%	+22.76%
10 years(CAGR)	+4.68%	+21.69%
Max(CAGR)	+12.84%	+14.76%

Winner

HOMB

+2.44%

XENE

-10.36%

HOMB

-0.83%

Winner

XENE

+23.02%

HOMB

-2.98%

Winner

XENE

+14.93%

HOMB

+0.39%

Winner

XENE

+68.34%

5Y(CAGR)

HOMB

+2.56%

Winner

XENE

+22.76%

10Y(CAGR)

HOMB

+4.68%

Winner

XENE

+21.69%

Max(CAGR)

HOMB

+12.84%

Winner

XENE

+14.76%

HOMB vs XENE - Annual Returns (2006 - 2026)

Returns include dividend reinvestment.

Year	HOMB	XENE
2026	-1.31%	+16.27%
2025	+2.71%	+11.58%
2024	+15.01%	-12.71%
2023	+16.48%	+23.62%
2022	-5.50%	+24.82%
2021	+27.67%	+111.94%
2020	+2.30%	+12.10%
2019	+22.07%	+96.26%
2018	-27.48%	+119.48%
2017	-14.11%	-64.01%
2016	+44.86%	-3.27%
2015	+29.34%	-57.01%
2014	-10.55%	+88.10%
2013	+123.80%	N/A
2012	+28.63%	N/A
2011	+14.12%	N/A
2010	+8.86%	N/A
2009	-8.65%	N/A
2008	+54.08%	N/A
2007	-13.02%	N/A
2006	+20.48%	N/A

HOMB vs XENE Drawdown Comparison

The maximum drawdown for HOMB was -62.98%, occurring on Mar 23, 2020. Recovery took 1011 trading sessions.

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The current HOMB drawdown is -11.75%. The current XENE drawdown is -17.57%.

Rank	HOMB	XENE
#1	-62.98% Mar 1, 2017 - Mar 8, 2021	-90.43% Jan 8, 2015 - Oct 4, 2021
#2	-52.62% Sep 18, 2008 - May 12, 2010	-43.59% Feb 9, 2024 - Mar 9, 2026
#3	-27.43% May 7, 2021 - Jul 16, 2024	-34.08% May 9, 2023 - Dec 22, 2023
#4	-26.94% Dec 23, 2013 - Jul 16, 2015	-30.14% Nov 5, 2021 - Aug 4, 2022
#5	-26.63% Nov 10, 2015 - Aug 30, 2016	-25.87% Nov 11, 2014 - Dec 11, 2014
#6	-23.12% Dec 27, 2006 - Jul 22, 2008	-17.57% Mar 9, 2026 - Jun 5, 2026
#7	-22.29% May 12, 2010 - Dec 22, 2011	-17.08% Mar 1, 2023 - May 3, 2023
#8	-21.44% Nov 26, 2024 - Apr 8, 2025	-16.98% Aug 24, 2022 - Feb 13, 2023
#9	-15.36% Sep 2, 2016 - Nov 10, 2016	-11.44% Oct 15, 2021 - Nov 2, 2021
#10	-12.09% Aug 14, 2015 - Oct 8, 2015	-11.09% Dec 11, 2014 - Dec 29, 2014
#11	-10.82% Jul 30, 2024 - Nov 6, 2024	-9.36% Feb 13, 2023 - Mar 1, 2023
#12	-10.78% Jul 3, 2006 - Nov 29, 2006	-8.58% Jan 8, 2024 - Feb 8, 2024
#13	-9.10% Dec 9, 2016 - Feb 27, 2017	-8.27% Aug 10, 2022 - Aug 24, 2022
#14	-9.02% Mar 12, 2021 - May 4, 2021	-6.08% Dec 29, 2014 - Jan 7, 2015
#15	-8.97% Aug 15, 2008 - Sep 3, 2008	-4.89% Dec 27, 2023 - Jan 8, 2024